Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gastrimmune phase I/II trial completed

April 12, 1996

Seed implant treatment effective in prostate cancer

April 5, 1996

Scotia accelerates development of temoporfin

April 5, 1996

Lu-Tex clinical update

April 5, 1996

New antitumor proteins from Alfacell

April 5, 1996

Oncogene Science, Pfizer extend research agreement

April 5, 1996

New telomerase inhibitor from Geron

April 5, 1996

Kyowa Hakko discloses UCF76-B

April 5, 1996

Regeneron investigates Tie-2 ligand

April 5, 1996

New angiogenesis inhibitors from ADIR

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 11, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.